Chimerism in the immunohematology laboratory in the molecular biology era

被引:14
作者
Bluth, Martin H.
Reid, Marion E.
Manny, Noga
机构
[1] Suny Downstate Med Ctr, Brooklyn, NY 11203 USA
[2] New York Blood Ctr, Lab Immunohematol, New York, NY 10021 USA
[3] Hebrew Univ Jerusalem, Hadassah Med Ctr, Blood Bank, IL-91905 Jerusalem, Israel
[4] Hebrew Univ Jerusalem, Hadassah Med Ctr, Transfus Med Dept, IL-91905 Jerusalem, Israel
基金
美国国家卫生研究院;
关键词
BONE-MARROW-TRANSPLANTATION; IN-VITRO FERTILIZATION; DONOR LEUKOCYTE INFUSIONS; MATERNAL PLASMA; FETAL DNA; CELL TRANSPLANTATION; PERIPHERAL-BLOOD; TETRAGAMETIC CHIMERISM; DISPERMIC CHIMERISM; ABO-INCOMPATIBILITY;
D O I
10.1016/j.tmrv.2006.11.002
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Dual or multiple cell populations, induced by chimeras, have been the subject of many studies. This long-standing fascination with chimeras has revealed a good deal of knowledge about human inheritance. Although historically most chimeras were caused by natural events, certain current medical intervention therapies are increasing the number of situations that can lead to a mixed cell population, that is, the chimeric condition, in humans. Medical therapies such as transfusion, stem cell transplantation, kidney transplantation, and artificial insemination induce temporary and sometimes permanent chimeras. Such natural or therapeutically induced presentations of chimerism can present challenging issues to the clinical immunohematology laboratory with regard to interpretation of results and subsequent patient management. The purpose of this review was to highlight some of these chimeric states and hypothesize how testing DNA from various tissues can cause apparent discrepancies between phenotype and genotype results. (c) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:134 / 146
页数:13
相关论文
共 70 条
[1]   Microchimerism - An investigative frontier in autoimmunity and transplantation [J].
Adams, KM ;
Nelson, JL .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 291 (09) :1127-1131
[2]  
Ainsworth C, 2003, NEW SCI, V180, P34
[3]   Detection of maternal progenitor cells in human umbilical cord blood by single-colony karyotyping [J].
Almici, C ;
CarloStella, C ;
Rizzoli, V ;
Wagner, JE .
BLOOD, 1996, 88 (04) :1520-1521
[4]   Genomic analysis of ABO chimeras and mosaicsusing hematopoietic colony-derived DNA [J].
Anan, K ;
Suzuki, H ;
Iwasaki, M ;
Kobayashi, K .
TRANSFUSION, 1999, 39 (11-12) :1247-1255
[5]   Long-term survive of ex-thalassemic patients with persistent mixed chimerism after bone marrow transplantation [J].
Andreani, M ;
Nesci, S ;
Lucarelli, G ;
Tonucci, P ;
Rapa, S ;
Angelucci, E ;
Persini, B ;
Agostinelli, F ;
Donati, M ;
Manna, M .
BONE MARROW TRANSPLANTATION, 2000, 25 (04) :401-404
[6]  
[Anonymous], HUMAN MOL GENETICS
[7]   Allogeneic transplantation using non-myeloablative transplant regimens [J].
Battiwalla, M ;
Barrett, J .
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2001, 14 (04) :701-722
[8]   Male fetal progenitor cells persist in maternal blood for as long as 27 years postpartum [J].
Bianchi, DW ;
Zickwolf, GK ;
Weil, GJ ;
Sylvester, S ;
DeMaria, MA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (02) :705-708
[9]  
BIRD GWG, 1982, J IMMUNOGENET, V9, P317
[10]   THE LIVERPOOL CHIMERA [J].
BROMILOW, IM ;
DUGUID, J .
VOX SANGUINIS, 1989, 57 (02) :147-149